Oncology Gold Standard(®) practical consensus recommendations for the use of monoclonal antibodies in the management of squamous cell carcinoma of head and neck

We present the 2017 Oncology Gold Standard Practical Consensus Recommendation for use of monoclonal antibodies in the management of advanced squamous cell carcinoma of head neck region.

Detalles Bibliográficos
Autores principales: Babu, Govind, Bahl, Ankur, Bhattacharya, G. S., Bhowmik, K. T., Dattatraya, P. S., Ghadyalpatil, Nikhil, Karandikar, S. M., Kulkarni, Padmaj, Sridharan, Nithya, Parikh, Purvish, Prabhash, Kumar, Raja, T., Rajasundaram, S., Subramanian, S., Talapatra, Kaustav, Vaid, Ashok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
ORIGINAL ARTICLE: Head and Neck Cancers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763625/
https://www.ncbi.nlm.nih.gov/pubmed/29404293
http://dx.doi.org/10.4103/sajc.sajc_181_17
Descripción
Sumario:We present the 2017 Oncology Gold Standard Practical Consensus Recommendation for use of monoclonal antibodies in the management of advanced squamous cell carcinoma of head neck region.

Ejemplares similares